Moms@Home: a storytelling mobile app to help manage blood pressure in pregnancy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Moms@Home pilot is a randomized controlled trial testing a storytelling-based mobile app combined with a digital home blood pressure monitor and a curated HBPM report to improve home blood pressure monitoring among pregnant people with chronic or gestational hypertension. Planned enrollment is 100 participants (about 50% from racial/ethnic minority groups) who are randomized to Moms@Home versus enhanced standard care (BP monitor and diary). The intervention uses culturally relevant storytelling videos, a patient dashboard of BP data, and automated reports to clinicians to support self-care and patient–provider communication. The primary outcome is adherence to home blood pressure monitoring, with secondary aims examining feasibility, acceptability, sustainability, and signals of impact on BP management and pregnancy-specific outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18-50
* English or Spanish speaking
* A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age)
* Singleton or multiple gestation pregnancy,
* A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts
* Willing to share home blood pressure monitoring data
* Comfortable with the use of smartphones and mobile apps

Exclusion Criteria:

* Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg)
* Current diagnosis of preeclampsia
* Active substance use
* Serious physical illness (e.g., unable to interact with a smart device)
* Enrolled in another home blood pressure monitoring program
* Excluded from study participation by their provider
* Inability to provide informed consent
* Prisoners/institutionalized individuals

Where it's running

• UMass Memorial Medical Center - Memorial Campus
  Worcester, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Lara Kovell, MD,MSc — University of Massachusetts Medical School, Worcester
• Study coordinator: Lara Kovell, MD,MSc
• Email: lara.kovell2@umassmed.edu
• Phone: (508) 856-2772

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using dapagliflozin to reduce cardiovascular risk after hypertensive pregnancies

  This study is testing if the medication dapagliflozin can help reduce heart risks for women who had high blood pressure during pregnancy after they give birth.

  Recruiting Phase 4 University of Michigan · Ann Arbor, Michigan · NCT06785116

• MH-Rx: Check-in on You, Your Medication, and Your Blood Pressure for Pregnant People

  This trial tests whether adding virtual social-support and medication management to remote blood pressure monitoring helps pregnant people with chronic or gestational hypertension.

  Recruiting Texas Southern University · Houston, Texas · NCT07842341

• Community health worker support to lower blood pressure after pregnancy with high blood pressure

  Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07778966

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

• Telehealth and remote blood pressure management for pregnant women with chronic high blood pressure

  This study tests whether alternating telehealth visits with home blood pressure monitoring and health coaching helps pregnant women (18–45) with chronic high blood pressure compared with standard in-person care.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT07356518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.